Luye Pharma Group Ltd. (OTCMKTS:LYPHF – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totaling 286,500 shares, a growth of 139.7% from the April 30th total of 119,500 shares. Based on an average trading volume of 18 shares, the short-interest ratio is presently 15,916.7 days.
Luye Pharma Group Price Performance
Shares of LYPHF stock remained flat at $0.33 on Friday. The business’s 50 day simple moving average is $0.35 and its two-hundred day simple moving average is $0.37. Luye Pharma Group has a 1 year low of $0.30 and a 1 year high of $0.33.
About Luye Pharma Group
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Read More
- Five stocks we like better than Luye Pharma Group
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
- 5 Under-the-Radar AI Stocks to Watch in June
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
